Contributor Disclosures for Osteoarthritis

Role Name Disclosure Details Author  Carlos J Lozada, MD, Director of Rheumatology Fellowship Program, Associate Professor, Department of Medicine, Division of Rheumatology and Immunology, Jackson Memorial Medical Center, University of Miami School of Medicine Nothing to disclose Details Coauthor  Eli Steigelfest, MD, Consulting Staff, Department of Rheumatology, The Consultant Group PC Nothing to disclose Details Medical Editor  John Varga, MD, Professor, Department of Internal Medicine, Division of Rheumatology, Northwestern University Nothing to disclose Details Pharmacy Editor  Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine Nothing to disclose Details Managing Editor  Elliot Goldberg, MD, Dean of the Western Pennsylvania Clinical Campus, Professor, Department of Medicine, Temple University School of Medicine Nothing to disclose Details CME Editor  Alex J Mechaber, MD, FACP, Assistant Dean for Medical Curriculum, Associate Professor of Medicine, Division of General Internal Medicine, University of Miami Miller School of Medicine Nothing to disclose Details Chief Editor  Herbert S Diamond, MD, Professor of Medicine, Temple University School of Medicine; Chairman, Department of Internal Medicine, Western Pennsylvania Hospital medifocus health dialogs Merck, Amgen, Wyeth, Johnson&Johnson, Stryker, Medtronic, Zimmer.Abbott, West Penn Allegheny Health System Pfizer Proctor&Gamble, Amgen, Pfizer Details Contributor Disclosure Contributor: Contributor Disclosure: Carlos J Lozada, Author  The contributor discloses no conflict of interest.  Contributor Disclosure Contributor: Contributor Disclosure: Eli Steigelfest, Coauthor  The contributor discloses no conflict of interest.  Contributor Disclosure Contributor: Contributor Disclosure: John Varga, Medical Editor  The contributor discloses no conflict of interest.  CONTRIBUTOR DISCLOSURE FORM Contributor Name: Francisco Talavera  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** Off label or investigational use of medication CONTRIBUTOR DISCLOSURE FORM Contributor Name: Elliot Goldberg  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** Off label or investigational use of medication Contributor Disclosure Contributor: Contributor Disclosure: Alex J Mechaber, CME Editor  The contributor discloses no conflict of interest.  CONTRIBUTOR DISCLOSURE FORM Contributor Name: Herbert S Diamond  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** medifocus Honoraria Review panel membership   health dialogs Honoraria Consulting   Merck, Amgen, Wyeth, Johnson&Johnson, Stryker, Medtronic, Zimmer.Abbott, Ownership interest Other   West Penn Allegheny Health System Salary Employment   Pfizer Honoraria Consulting   Proctor&Gamble, Amgen, Pfizer Grant/research funds Independent contractor   Off label or investigational use of medication